Loading...
Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2
OBJECTIVES: Efforts to develop and deploy effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) continue at pace. Here, we describe rational antigen design through to manufacturability and vaccine efficacy of a prefusion‐stabilised spike (S) protein, Sclamp, in comb...
Na minha lista:
Udgivet i: | Clin Transl Immunology |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
John Wiley and Sons Inc.
2021
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8021130/ https://ncbi.nlm.nih.gov/pubmed/33841880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1269 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|